Catecholamine phenotyping: Clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 1781-1790

  Goldstein, David S ^a   Lenders, Jacques W M ^b   Kaler, Stephen G ^a   Eisenhofer, Graeme ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Catecholamines; DOPA; Dopamine; Neurochemistry; Neurogen etics; Norepinephrine; Phenotype

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; AMINE OXIDASE (FLAVIN CONTAINING); AROMATIC LEVO AMINO ACID DECARBOXYLASE; COPPER; DIHYDROPTERIDINE REDUCTASE; DOPA; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; HOMOVANILLIC ACID; METADRENALIN; NORADRENALIN; NORMETADRENALIN;

CATECHOLAMINE SYNTHESIS; DIGEORGE SYNDROME; DYSTONIA; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; MENKES SYNDROME; MOLECULAR DYNAMICS; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; VITILIGO; VON HIPPEL LINDAU DISEASE;

EID: 0029797116     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67051781.x     Document Type: Review

References (87)

1. Adler C., Ghisla S., Rebrin L, Haavik J., Heizmann C. W., Blau N., Kuster T., and Curtius H. C. (1992) 7-Substituted pterins in humans with suspected pterin-4a-carbinolamine dehydratase deficiency. Mechanism of formation via non-enzymatic transformation from 6-substituted pterins. Eur. J. Biochem. 208, 139-144.
2. Aksoy I. A. and Weinshilboum R. M. (1995) Human thermolabile phenol sulfotransferase gene (STM): molecular cloning and structural characterization. Biochem. Biophys. Res. Commun. 208, 786-795.
3. Aksoy I. A., Callen D. F., Apostolou S., Her C., and Weinshilboum R. M. (1994) Thermolabile phenol sulfotransferase gene (STM): localization to human chromosome 16pl 1.2. Genomics 23, 275-277.
4. Axelrod F., Goldstein D. S., Holmes C., Berlin D., and Kopin I. J. (1996) Pattern of plasma levels of catechols in familial dysautonomia. Clin. Auton. Res. (in press).
5. Blumenfeld A., Slaugenhaupt S. A., Axelrod F. B., Lucente D. E., Maayan C., Liebert C. B., Ozelius L. J., Trofatter J. A., Haines J. L., and Breakefield X. O. (1993) Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat. Genet. 4, 160-164.
6. Breakefield X. O., Orloff G., Castiglione C., Coussens L., Axelrod F. B., and Ullrich A. (1984) Structural gene for beta-nerve growth factor not defective in familial dysautonomia. Proc. Natl. Acad. Sci. USA 81, 4213-4216.
7. Brunner H. G., Nelen M., Breakefield X. O., Ropers H. H., and van Oost B. A. (1993a) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580.
8. Brunner H. G., Nelen M. R., van Zandvoort P., Abeling N. G., van Gennip A. H., Wolters E. C., Kuiper M. A., Ropers H. H., and van Oost B. A. (1993b) X-Linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism [see comments]. Am. J. Hum. Genet. 52, 1032-1039.
9. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., and Shih J. C. (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766.
10. Chelly J., Turner Z., Tonnesen T., Petterson A., Ishikawa-Brush Y., Tommerup N., Horn N., and Monaco A. P. (1993) Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein [see comments]. Nat. Genet. 3, 14-19.
11. Choyke P. L., Glenn G. M., Walther M. M., Patronas N. J., Linehan W. M., and Zbar B. (1995) Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194, 629-642.
12. Citron B. A., Kaufman S., Milstien S., Naylor E. W., Greene C. L., and Davis M. D. (1993) Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. Am. J. Hum. Genet. 53, 768-774.
13. Collins F. A., Murphy D. L., Reiss A. L., Sims K. B., Lewis J. G., Freund L., Karoum F., Zhu D., Maumenee I. H., and Antonarakis S. E. (1992) Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am. J. Med. Genet. 42, 127-134.
14. Craig S. P., Thai A. L., Weber M., and Craig I. W. (1992) Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13→p11 by in situ hybridisation. Cytogenet. Cell Genet. 61, 114-116.
15. Crossey P. A., Eng C., Ginalska-Malinowska M., Lennard T. W., Wheeler D. C., Ponder B. A., and Maher E. R. (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J. Med. Genet. 32, 885-886.
16. Das S., Levinson B., Whitney S., Vulpe C., Packman S., and Gitschier J. (1994) Diverse mutations in patients with Menkes disease often lead to exon skipping. Am. J. Hum. Genet. 55, 883-889.
17. Davis M. D., Ribeiro P., Tipper J., and Kaufman S. (1992) "7-Tetrahydrobiopterin," a naturally occurring analogue of tetra-hydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. Proc. Natl. Acad. Sci. USA 89, 10109-10113.
18. Dhondt J. L. (1984) Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey. J. Pediatr. 104, 501-508.
19. Dianzani I., Howells D. W., Ponzone A., Saleeba J. A., Smooker P. M., and Cotton R. G. (1993) Two new mutations in the dihydropteridine reductase gene in patients with tetrahydrobiopterin deficiency. J. Med. Genet. 30, 465-469.
20. Dousa M. K. and Tyce G. M. (1988) Free and conjugated plasma catecholamines, DOPA and 3-O-methyldopa in humans and in various animal species. Proc. Soc. Exp. Biol. Med. 188, 427-434.
21. Dunham I., Collins J., Wadey R., and Scambler P. (1992) Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 340, 1361-1362.
22. Eisenhofer G., Esler M. D., Meredith I. T., Dart A., Cannon R. O. III, Quyyumi A. A., Lambert G., Chin J., Jennings G. L., and Goldstein D. S. (1992) Sympathetic nervous function in the human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation 85, 1775-1785.
23. Franke U. C., Scambler P. J., Loffler C., Lons P., Hanefeld F., Zoll B., and Hansmann I. (1994) Interstitial deletion of 22q11 in DiGeorge syndrome detected by high resolution and molecular analysis. Clin. Genet. 46, 187-192.
24. Furukawa Y., Shimadzu M., Rajput A. H., Shimizu Y., Tagawa T., Mori H., Yokochi M., Narabayashi H., Hornykiewicz O., Mizuno Y., and Kish S. J. (1996) GTP-cyclohydrolase I gene mutations in hereditary progressive and DOPA-responsive dystonia. Ann. Neurol. 39, 609-617.
25. Giros G., Jaber M., Jones S. R., Wightman R. M., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
26. Goldstein D. S., Udelsman R., Eisenhofer G., Stull R., Keiser H. R., and Kopin I. J. (1987) Neuronal source of plasma dihydroxyphenylalanine. J. Clin. Endocrinol. Metab. 64, 856-861.
27. Goldstein D. S., Polinsky R. J., Garty M., Robertson D., Brown R. T., Biaggioni I., Stull R., and Kopin I. J. (1989) Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann. Neurol. 26, 558-563.
28. Goldstein D. S., Hahn S.-H., Holmes C., Tifft C., Harvey-White J., Milstien S., and Kaufman S. (1995) Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency. J. Neurochem. 64, 2810-2813.
29. Gross D. J., Avishai N., Meiner V., Filon D., Zbar B., and Abeliovich D. (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J. Clin. Endocrinol. Metab. 81, 147-149.
30. Gunn T. R., Macfarlane S., and Phillips L. I. (1984) Difficulties in the neonatal diagnosis of Menkes' kinky hair syndrome - trichopoliodystrophy. Clin. Pediatr. (Phila.) 23, 514-516.
31. Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., and Linehan W. M. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91, 9700-9704.
32. Hirano M., Tamaru Y., Nagai Y., Ito H., Imai T., and Ueno S. (1995) Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. Biochem. Biophys. Res. Commun. 213, 645-651.
33. Hyland K., Surtees R. A., Rodeck C., and Clayton P. T. (1992) Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 42, 1980-1988.
34. Hyland K., Surtees R. A., Heales S. J., Bowron A., Howells D. W., and Smith I. (1993) Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr. Res. 34, 10-14.
35. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., and Tsuji S. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8, 236-242.
36. Irons M., Levy H. L., O'Flynn M. E., Stack C. V., Langlais P. J., Butler I. J., Milstien S., and Kaufman S. (1987) Folinic acid therapy in treatment of dihydropteridine reductase deficiency. J. Pediatr. 110, 61-67.
37. Kaler S. G. (1994) Menkes disease. Adv. Pediatr. 41, 263-304.
38. Kaler S. G. (1996) Menkes disease mutations and response to early copper histidine treatment. Nat. Genet. 13, 21-22.
39. Kaler S. G., Gahl W. A., Berry S. A., Holmes C. S., and Goldstein D. S. (1993a) Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease. J. Inherit. Metab. Dis. 16, 907-908.
40. Kaler S. G., Goldstein D. S., Holmes C., Salerno J. A., and Gahl W. A. (1993b) Plasma and cerebrospinal fluid neurochemical pattern in Menkes' disease. Ann. Neurol. 33, 171-175.
41. Kaler S. G., Gallo L. K., Proud V. K., Percy A. K., Mark Y., Segal N. A., Goldstein D. S., Holmes C. S., and Gahl W. A. (1994) Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat. Genet. 8, 195-202.
42. Kaler S. G., Buist N. R., Holmes C. S., Goldstein D. S., Miller R. C., and Gahl W. A. (1995) Early copper therapy in classic Menkes disease patients with a novel splicing mutation. Ann. Neurol. 38, 921-928.
43. Kaler S. G., Das S., Levinson B., Goldstein D. S., Holmes C. S., Patronas N. J., Packman S., and Gahl W. A. (1996) Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small in-frame deletion. Biochem. Mol. Med. 57, 37-46.
44. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., and Krumholz A. (1975a) Phenylketonuria due to a deficiency of dihydropteridine reductase. N. Engl. J. Med. 293, 785-790.
45. Kaufman S., Milstien S., and Bartholome K. (1975b) New forms of phenylketonuria. Lancet 2, 708.
46. Kuchel O., Buu N. T., Unger T., and Genest J. (1978) Free and conjugated catecholamines in human hypertension. Clin. Sci. 55, 77s-80s.
47. Kuchel O., Buu N. T., Hamet P., Larochelle P., Bourque M., and Genest J. (1981) Essential hypertension with low conjugated catecholamines imitates pheochromocytoma. Hypertension 3, 347-355.
48. Latif F., Tory K., Gnarra J., Yao M., Duh F. M., Orcutt M. L., Stackhouse T., Kuzmin I., Modi W., and Geil L. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317-1320.
49. Lenders J. W., Keiser H. R., Goldstein D. S., Willemsen J. J., Friberg P., Jacobs M. C., Kloppenborg P. W., Thien T., and Eisenhofer G. (1995) Plasma metanephrines in the diagnosis of pheochromocytoma. Ann. Intern. Med. 123, 101-109.
50. Lenders J. W. M., Eisenhofer G., Abeling N. G. G. M., Berger W., Murphy D. L., Konings C. H., Wagemakers L. M. B., Kopin I. J., Karoum F., van Gennip A. H., and Brunner H. G. (1996) Specific genetic deficiencies of the A and B isozymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest. 97, 1010-1019.
51. Linehan W. M., Lerman M. I., and Zbar B. (1995) Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273, 564-570.
52. Matsubara Y., Ikeda H., Endo H., and Narisawa K. (1992) Dried blood spot on filter paper as a source of mRNA. Nucleic Acids Res. 20, 1998.
53. Mercer J. F., Livingston J., Hall B., Paynter J. A., Begy C., Chandrasekharappa S., Lockhart P., Grimes A., Bhave M., and Siemieniak D. (1993) Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3, 20-25.
54. Morrone A., Picardo M., de Luca C., Terminali O., Passi S., and Ippolito F. (1992) Catecholamines and vitiligo. Pigment Cell Res. 5, 65-69.
55. Neumann H. P. H., Eng C., and Mulligan L. M. (1996) Von Hippel-Lindau disease and pheochromocytoma. JAMA 275, 280.
56. Niederwieser A., Blau N., Wang M., Joller P., Atares M., and Cardesa-Garcia J. (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141, 208-214.
57. Niederwieser A., Ponzone A., and Curtius H. C. (1985) Differential diagnosis of tetrahydrobiopterin deficiency. J. Inherit. Metab. Dis. 8 (Suppl. 1), 34-38.
58. Nygaard T. G. (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv. Neurol. 60, 577-585.
59. Nygaard T. G., Wilhelmsen K. C., Risch N. J., Brown D. L., Trugman J. M., Gilliam T. C., Fahn S., and Weeks D. E. (1993) Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat. Genet. 5, 386-391.
60. Nygaard T. G., Waran S. P., Levine R. A., Naini A. B., and Chutorian A. M. (1994) Dopa-responsive dystonia simulating cerebral palsy. Pediatr. Neurol. 11, 236-240.
61. O'Connor D. T., Cervenka J. H., Stone R. A., Levine G. L., Parmer R. J., Franco-Bourland R. E., Madrazo I., Langlais P. J., Robertson D., and Biaggioni I. (1994) Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central nonradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin. Sci. (Colch). 86, 149-158.
62. O'Malley K. L., Harmon S., Moffat M., Uhland-Smith A., and Wong S. (1995) The human aromatic L-amino acid decarboxylase gene can be alternatively spliced to generate unique protein isoforms. J. Neurochem. 65, 2409-2416.
63. Orecchia G., Frattini P., Cucchi M. L., and Santagostino G. (1994) Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report. Dermatology 189, 350-353.
64. Pollock R. J. and Kaufman S. (1978) Dihydropteridine reductase may function in tetrahydrofolate metabolism. J. Neurochem. 31, 115-123.
65. Rajput A. H., Gibb W. R., Zhong X. H., Shannak K. S., Kish S., Chang L. G., and Hornykiewicz O. (1994) Dopa-responsive dystonia: pathological and biochemical observations in a case [see comments]. Ann. Neurol. 35, 396-402.
66. Ratge D., Kohse K. P., Steegmuller U., and Wisser H. (1991) Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations. J. Pharmacol. Exp. Ther. 257, 232-238.
67. Robertson D., Goldberg M. R., Onrot J., Hollister A. S., Wiley R., Thompson J. G. Jr., and Robertson R. M. (1986) Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N. Engl. J. Med. 314, 1494-1497.
68. Robertson D., Beck C., Gary T., and Picklo M. (1993) Classification of autonomic disorders. Int. Angiol. 12, 93-102.
69. Scambler P. J., Kelly D., Lindsay E., Williamson R., Goldberg R., Shprintzen R., Wilson D. I., Goodship J. A., Cross I. E., and Burn J. (1992) Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 339, 1138-1139.
70. Schallreuter K. U., Wood J. M., Ziegler L, Lemke K. R., Pittelkow M. R., Lindsey N. J., and Gutlich M. (1994) Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim. Biophys. Acta 1226, 181-192.
71. Scherer L. J., McPherson J. D., Wasmuth J. J., and Marsh J. L. (1992) Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics 13, 469-471.
72. Scriver C. R., Kaufman S., Eisensmith R. C., and Woo S. L. C. (1996) The hyperphenylalaninemias, in The Metabolic and Molecular Bases of Inherited Disease (Scriver C. R., Beaudet A. L., Sly W. S., and Valle D., eds), pp. 1015-1075. McGraw-Hill, New York.
73. Slaugenhaupt S. A., Blumenfeld A., Liebert C. B., Mull J., Lucente D. E., Monahan M., Breakefield X. O., Maayan C., Parada L., and Axelrod F. B. (1995) The human gene for neurotrophic tyrosine kinase receptor type 2 (NTRK2) is located on chromosome 9 but is not the familial dysautonomia gene. Genomics 25, 730-732.
74. Smith A. A., Taylor T., and Wortis B. (1963) Abnormal catecholamine metabolism in familial dysautonomia. N. Engl. J. Med. 268, 705-707.
75. Smooker P. M., Howells D. W., and Cotton R. G. (1993) Identification and in vitro expression of mutations causing dihydropteridine reductase deficiency. Biochemistry 32, 6443-6449.
76. Smooker P. M., Christodoulou J., McInnes R. R., and Cotton R. G. (1995) A mutation causing DHPR deficiency results in a frameshift and a secondary splicing defect. J. Med. Genet. 32, 220-223.
77. Sumi S., Ishikawa T., Ito Y., Oishi H., Asai K., and Wada Y. (1990) Probable assignment of the dihydropteridine reductase gene to 4p15.31. Tohoku J. Exp. Med. 160, 93-94.
78. Takahashi H., Levine R. A., Galloway M. P., Snow B. J., Calne D. B., and Nygaard T. G. (1994) Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann. Neurol. 35, 354-356.
79. Taschner P. E., de Vos N., Thompson A. D., Callen D. F., Doggett N., Mole S. E., Dooley T. P., Barth P. G., and Breuning M. H. (1995) Chromosome 16 microdeletion in a patient with juvenile neuronal ceroid lipofuscinosis (Batten disease). Am. J. Hum. Genet. 56, 663-668.
80. Thomas S. A., Matsumoto A. M., and Palmiter R. D. (1995) Noradrenaline is essential for mouse fetal development. Nature 374, 643-646.
81. Toth L. A., Scott M. C., and Elchisak M. A. (1986) Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci. 39, 519-526.
82. Turner Z., Horn N., Tonnesen T., Christodoulou J., Clarke J. T., and Sarkar B. (1996) Early copper-histidine treatment for Menkes disease. Nat. Genet. 12, 11-13.
83. Vulpe C., Levinson B., Whitney S., Packman S., and Gitschier J. (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 3, 7-13.
84. Wilson D. I., Goodship J. A., Burn J., Cross I. E., and Scambler P. J. (1992) Deletions within chromosome 22q11 in familial congenital heart disease. Lancet 340, 573-575.
85. Zhou Q. Y., Quaife C. J., and Palmiter R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.
86. Ziegler M. G., Lake C. R., and Kopin I. J. (1976) Deficient sympathetic nervous response in familial dysautonomia. N. Engl. J. Med. 294, 630-633.
87. Ziegler M. G., Lake C. R., and Kopin I. J. (1977) The sympatheticnervous-system defect in primary orthostatic hypotension. N. Engl. J. Med. 296, 293-297.